|Articles|June 15, 2003
- BioPharm International-06-01-2003
- Volume 16
- Issue 6
Collaborating Across the Extended Pharmaceutical Enterprise: How Sharing Information Leads to Process Enablement
Author(s)Peter Loupos, Andrew Grygiel
by Peter Loupos, Aventis Drug Innovation and Approval and Andrew Grygiel A collaborative framework can be a driver for cultural change, encouraging knowledge sharing between internal and external personnel and improving innovation and productivity throughout the enterprise.
Advertisement
Articles in this issue
over 22 years ago
SOX in the Boardroom: What the Sarbanes?Oxley Act Means to Youover 22 years ago
Inside Washington: Reshaping Biotech Drug Developmentover 22 years ago
BioTrends: M&A MalaiseNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
